CCO Oncology Podcast
A podcast by Clinical Care Options
189 Episodes
-
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the Netherlands and the United Kingdom
Published: 11/20/2020 -
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France
Published: 11/19/2020 -
Molecular Classification of Endometrial Carcinoma in the Clinic Today
Published: 11/11/2020 -
Advances in Immunotherapy for Endometrial Cancer
Published: 11/11/2020 -
Developments in Acute Leukemias: Expert Answers to Clinician Questions
Published: 10/2/2020 -
Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy
Published: 10/2/2020 -
Biomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond
Published: 10/2/2020 -
Experts Discuss Evolving State-of-the-Art Management of Patients With HER2-Positive MBC
Published: 9/21/2020 -
The Art of Medicine: Clinical Considerations for Patients With Advanced RCC
Published: 9/21/2020 -
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1
Published: 9/17/2020 -
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3
Published: 9/17/2020 -
Clinical Considerations for <em>RET</em> Fusion–Positive NSCLC
Published: 9/17/2020 -
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2
Published: 9/16/2020 -
CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions
Published: 9/14/2020 -
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond
Published: 9/8/2020 -
FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma
Published: 9/3/2020 -
New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments
Published: 9/1/2020 -
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy
Published: 8/31/2020 -
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma
Published: 8/31/2020 -
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1
Published: 8/28/2020
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.